Skip to main navigation Skip to search Skip to main content

Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years — 18 U.S. Jurisdictions, September 2021–December 2022

  • Kevin C. Ma*
  • , Vajeera Dorabawila
  • , Tomás M. León
  • , Hannah Henry
  • , Amelia G. Johnson
  • , Eli Rosenberg
  • , Joshua A. Mansfield
  • , Claire M. Midgley
  • , Ian D. Plumb
  • , Julia Aiken
  • , Quratul Ain Khanani
  • , Steven Auche
  • , Nagla S. Bayoumi
  • , Sarah A. Bennett
  • , Carmen Bernu
  • , Carolyn Chang
  • , Kathryn J. Como-Sabetti
  • , Kevin Cueto
  • , Spencer Cunningham
  • , Meredith Eddy
  • Rebecca A. Falender, Aaron Fleischauer, Darren M. Frank, Pauline Harrington, Mikhail Hoskins, Adam Howsare, Lucy M. Ingaiza, Aras S. Islam, Shelli A. Jensen, Jefferson M. Jones, Grace Kambach, F. N.U. Kanishka, Yuriy Levin, John F. Masarik, Stephanie D. Meyer, Lauren Milroy, Keeley J. Morris, John Olmstead, Nina S. Olsen, Enaholo Omoike, Komal Patel, Amanda Pettinger, Melissa A. Pike, Isaiah G. Reed, Elizabeth Slocum, Melissa Sutton, Buddhi P. Tilakaratne, Hailey Vest, Johanna Vostok, Jennifer S. Wang, Lydia Watson-Lewis, Haley N. Wienkes, Melissa Briggs Hagen, Benjamin J. Silk, Heather M. Scobie
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Abstract

What is already known about this topic? Although SARS-CoV-2 reinfections have increased, U.S. epidemiologic trends and associated severe outcomes have not been characterized. What is added by this report? During September 2021–December 2022, the percentages of reinfections among all COVID-19 cases, hospitalizations, and deaths reported by 18 U.S. jurisdictions increased substantially as new Omicron lineages became predominant. Increases were more pronounced among adults aged 18–49 years compared with those among older persons. What are the implications for public health practice? Cases and severe outcomes associated with SARS-CoV-2 reinfection have increased across the United States since September 2021. CDC recommends staying up to date with COVID-19 vaccinations and receiving early antiviral treatment, if eligible, to reduce the risk for severe COVID-19–associated outcomes.

Original languageEnglish
Pages (from-to)683-689
Number of pages7
JournalMorbidity and Mortality Weekly Report
Volume72
Issue number25
DOIs
Publication statusPublished - 23 Jun 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 Department of Health and Human Services. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years — 18 U.S. Jurisdictions, September 2021–December 2022'. Together they form a unique fingerprint.

Cite this